| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/19/2004 | WO2004069406A1 Novel supported catalyst systems |
| 08/19/2004 | WO2004069191A2 Identification of t1r and t2r modulators |
| 08/19/2004 | WO2004069166A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | WO2004027067A3 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 08/19/2004 | WO2004026120A3 Methods for diagnosing and treating tumors and suppressing cd promoters |
| 08/19/2004 | WO2004024076A9 Novel compositions and methods for the treatment of immune related diseases |
| 08/19/2004 | WO2004010957B1 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 08/19/2004 | WO2004006756A3 THERAPIES FOR RENAL FAILURE USING INTERFERON-β |
| 08/19/2004 | WO2004005480A3 Plastid genetic engineering via somatic embryogenesis |
| 08/19/2004 | WO2003089607A3 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 08/19/2004 | WO2003068799A3 Oligomeric molecules and uses thereof |
| 08/19/2004 | WO2003060084A3 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 08/19/2004 | US20040163140 Biological material |
| 08/19/2004 | US20040163136 SEL-12 related methods |
| 08/19/2004 | US20040162244 Novel peptides use as angiotensin converting enzyme inhibitor and preparation process thereof |
| 08/19/2004 | US20040162236 Providing a sample; introducing the sample to an antibody that binds immunospecifically to the polypeptide (containing amino acids from 1 to 82 ); and determining the presence or amount of antibody bound to said polypeptide, thus determining the presence or amount of polypeptide in the sample |
| 08/19/2004 | US20040161846 Producing variant viral protein from negative sense single-stranded RNA virus for use as tool in vaccine development and prevention of viral infections; viricides |
| 08/19/2004 | US20040161841 Vector coding triosephosphate isomerase and heterologous nucleotide sequences for use in producing genetic vaccines; bioreactors |
| 08/19/2004 | US20040161827 Comprises nucleotide sequences coding tumor suppression phosphoprotein for use as pesticide and in treatment of cell proliferative disorders; antitumor agents; bioreactors and in vitro/in vivo drug screening |
| 08/19/2004 | US20040161825 Sperm specific proteins |
| 08/19/2004 | US20040161824 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 08/19/2004 | US20040161822 Protein having antithrombotic activity and method for producing the same |
| 08/19/2004 | US20040161817 for gene overexpression in combination with an immortalized host cell-line capable of growth in serum-free, suspension culture |
| 08/19/2004 | US20040161816 Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161795 Systems and methods for analysis of protein post-translational modification |
| 08/19/2004 | US20040161748 Gridded microarray created by transcription and translation of DNA, or by translation of mRNA, by a cell free system for generating heterologous proteins, domains or peptides; bioreactors |
| 08/19/2004 | US20040161739 HIV diagnostic methods |
| 08/19/2004 | US20040161427 Immunogen adherence and method of making and using same |
| 08/19/2004 | CA2515123A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2514983A1 Novel supported catalyst systems |
| 08/19/2004 | CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | CA2513833A1 Use of oxalate deficient aspergillus niger strains for producing a polypeptide |
| 08/19/2004 | CA2512624A1 Rat receptor tyrosine kinase, kdr |
| 08/18/2004 | EP1446733A2 Glycosylphosphatidylinositol containing polypeptides |
| 08/18/2004 | EP1446504A2 Emulsion compositions |
| 08/18/2004 | EP1446495A2 Whole cell engineering using real-time metabolic flux analysis |
| 08/18/2004 | EP1446484A1 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same |
| 08/18/2004 | EP1446478A2 Dimerized growth factor and materials and methods for producing it |
| 08/18/2004 | EP1446426A2 Peptide purification by means of metal ion affinity chromatography |
| 08/18/2004 | EP1446422A2 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446417A2 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 08/18/2004 | EP1446158A2 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4 |
| 08/18/2004 | EP1446130A2 Ehrlichia canis genes and vaccines |
| 08/18/2004 | EP1183346A4 Method for generating split, non-transferable genes that are able to express an active protein product |
| 08/18/2004 | EP0977856B1 Lag-3 splice variants |
| 08/18/2004 | EP0954330A4 Intestinal trefoil proteins |
| 08/18/2004 | EP0871474A4 Generation of human insulin |
| 08/18/2004 | EP0833920B1 Transferrin receptor genes |
| 08/18/2004 | EP0827544B1 Multimeric proteins |
| 08/18/2004 | EP0820507B1 Ndf peptides |
| 08/18/2004 | EP0817851B9 Dna encoding human papilloma virus type 18 |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | EP0471011B2 HUMAN LACTOFERRIN cDNA SEQUENCE |
| 08/18/2004 | CN1522299A Coagulation factor vii derivatives |
| 08/18/2004 | CN1522264A 抗cd40单克隆抗体 Monoclonal antibody anti-cd40 |
| 08/18/2004 | CN1521265A Method for preparing plant peptone |
| 08/18/2004 | CN1521264A Process for preparing serine-rich protein employing cysteine synthase (cysk) gene |
| 08/18/2004 | CN1162446C Insulinotropic hormone secretion peptide derivative |
| 08/18/2004 | CN1162182C Method of protein production using chondriosome translation system |
| 08/17/2004 | US6777540 Humanized immunoglobulin reacting specifically with Fas ligand or active fragments thereof and region inducing apoptosis originating in Fas ligand |
| 08/17/2004 | US6777538 Binding protein |
| 08/17/2004 | US6777219 Form fungi culture; for pretanning leather |
| 08/17/2004 | US6777202 Process for the recombinant production of s-layer proteins in gram-negative host cells |
| 08/17/2004 | US6777194 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 08/17/2004 | US6777192 Contacting the sample with an isolated recombinant immunodominant neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex |
| 08/17/2004 | US6777178 Antibodies for judging possibility of the onset of bovine leukemia |
| 08/17/2004 | CA2258153C Hepatocyte growth factor receptor agonists and uses thereof |
| 08/12/2004 | WO2004067728A2 Methods and systems for the identification of rna regulatory sequences and compounds that modulate their function |
| 08/12/2004 | WO2004067571A1 Monoclonal antibody against human hepatoma and use thereof |
| 08/12/2004 | WO2004067554A2 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | WO2004042003A3 Cell lysis compositions, methods of use, apparatus, and kit |
| 08/12/2004 | WO2004032860A3 Hiv vaccine formulations |
| 08/12/2004 | WO2004020585A3 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 08/12/2004 | WO2004011611A3 Taci antibodies and uses thereof |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | WO2002077179A8 Leinamycin biosynthesis gene cluster and its components and their uses |
| 08/12/2004 | US20040158045 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 08/12/2004 | US20040158044 Comprises polypeptide which binds major histocompatibility complex for use in cancer diagnosis and treatment; antitumor agents |
| 08/12/2004 | US20040157788 production of antibodies containing K light chains, in order to provide high affinity reproducibly |
| 08/12/2004 | US20040157775 Effector proteins of rapamycin |
| 08/12/2004 | US20040157310 Methods for enhancing the production of viral vaccines in cell culture |
| 08/12/2004 | US20040157300 Glycoprotein vi fusion proteins |
| 08/12/2004 | US20040157291 expressed sequence tag (EST); of fusion proteins comprising the first N-terminal domain of the geneIII protein of filamentous phage as fusion partner for the expression of a fused (poly)peptide/protein |
| 08/12/2004 | US20040157290 Process for preparing serine-rich protein employing cysteine synthase (cysK) gene |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157258 Isolated nucleic acid comprising polynucleotide of given sequence; screening methods for identifying binding partners of polypeptides; use in diagnosis and treatment |
| 08/12/2004 | US20040157242 Analyzing sample from patient and comparing to reference population both containing measurable amount of a low molecular weight compound (polypeptide); data analysis algorithm; mass spectrometry, liquid chromatography |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040156848 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 08/12/2004 | US20040156841 Human amine transporter |
| 08/12/2004 | US20040156838 inducing cytotoxic T-lymphocytes that will specifically down-regulate B-cells producing autologous IgE, notably by means of nucleic acid vaccination or live vaccination; inducing a combined antibody and CTK response specific for IgE |
| 08/12/2004 | CA2514580A1 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | CA2457607A1 Method of mutagenic chain reaction |
| 08/11/2004 | EP1445326A2 Practical in vitro sialylation of recombinant glycoproteins |
| 08/11/2004 | EP1445315A1 Human and mammalian stem cell-derived neuronal survival polypeptides |
| 08/11/2004 | EP1444603A2 Noe-nmr based methods for the identifycation of compounds which can bind to membrane receptors |
| 08/11/2004 | EP1444367A1 Reca-negative and rhab-negative microorganism |